Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia

Recent Results Cancer Res. 1993:131:249-56. doi: 10.1007/978-3-642-84895-7_22.

Authors

R Pieters¹, G J Kaspers, E R van Wering, D R Huismans, A H Loonen, K Hählen, A J Veerman

Affiliation

¹ Free University Hospital, Department of Pediatrics, Amsterdam, The Netherlands.

PMID: 8210644
DOI: 10.1007/978-3-642-84895-7_22

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / pharmacology*
Burkitt Lymphoma / drug therapy
Burkitt Lymphoma / immunology
Burkitt Lymphoma / pathology
Child
Drug Resistance
Drug Screening Assays, Antitumor
Humans
Immunophenotyping*
Leukemia-Lymphoma, Adult T-Cell / drug therapy
Leukemia-Lymphoma, Adult T-Cell / immunology
Leukemia-Lymphoma, Adult T-Cell / pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology

Substances

Antineoplastic Agents